Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > ULURU Inc. Announces the Appointment of Ronald A. Ahrens to the Board of Directors

Abstract:
ULURU Inc. (Amex: ULU) announced today that Ronald A. Ahrens has been appointed to serve on the
Company's Board of Directors.

ULURU Inc. Announces the Appointment of Ronald A. Ahrens to the Board of Directors

ADDISON, TX | Posted on June 23rd, 2008

Mr. Ahrens has been an advisor to Merck & Company, Inc. since 1995, when
he retired as President of Merck Consumer Healthcare Group Worldwide. He had
previously served as Executive Vice President of Merck Consumer Healthcare
Group International. From 1985 to 1990 Mr. Ahrens was Consumer Group
President, North America of Bristol-Myers Squibb and previously was President
of Bristol Myers Products Division. Prior to 1985, he held senior management
and sales and marketing positions with Richardson Vicks, Bristol-Myers Squibb
and Procter and Gamble.

"I am extremely impressed with ULURU's range of innovative products and
look forward to providing insight and guidance as they commercialize their
numerous product opportunities. The company is now at a point where I believe
my experience can assist the company to enhance share holder value," said Mr.
Ahrens.

Commenting on the appointment, Kerry P. Gray, President and Chief
Executive Officer of ULURU, stated, "We are excited to have Ron join our
Board, as he has vast experience successfully commercializing numerous
products, and has been involved with a wound care company. His extensive
industry experience and contacts will be extremely helpful as we commercialize
products both internally and with strategic partners."

####

About ULURU Inc.
ULURU Inc. is a specialty pharmaceutical company focused on the
development of a portfolio of wound management, plastic surgery and oral care
products to provide patients and consumers improved clinical outcomes through
controlled delivery utilizing its innovative transmucosal delivery system and
Hydrogel Nanoparticle Aggregate technology.

This press release contains certain statements that are forward-looking
within the meaning of Section 27a of the Securities Act of 1933, as amended,
including but not limited to statements made relating to the value of our
products in the marketplace, our ability to develop and market our
technologies and commercialization of products in the marketplace. These
statements are subject to numerous risks and uncertainties, including but not
limited to the risk factors detailed in the Company's Annual Report on Form
10-KSB for the year ended December 31, 2007, Quarterly Report on Form 10-Q for
the quarter ended March 31, 2008 and other reports filed by us with the
Securities and Exchange Commission.

For more information, please click here

Contacts:
Kerry P. Gray
President & CEO
Terry K. Wallberg
Vice President & CFO
(214) 905-5145

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

National Science Foundation Selects SUNY Poly CNSE for Expanded $2.1M Northeast Advanced Technological Education Center: NSF Center Locates to NanoCollege in Support of Flourishing Tech Industry in NYS September 1st, 2015

RUSNANOPRIZE Directorate Announces New Deadline for Nominations Submission September 11, 2015 September 1st, 2015

$200K Awarded to Develop In Vitro Lung Test for Toxicity of Inhaled Nanomaterials: In Vitro Lung Test Designed to Protect Human Health and Replace Animal Testing September 1st, 2015

Hot electrons point the way to perfect light absorption: Physicists study how to achieve perfect absorption of light with the help of rough ultrathin films September 1st, 2015

Nanomedicine

Using DNA origami to build nanodevices of the future September 1st, 2015

Efficiency of Nanodrug Containing Antibiotics in Treatment of Infectious Diseases Evaluated August 31st, 2015

Researchers use DNA 'clews' to shuttle CRISPR-Cas9 gene-editing tool into cells August 30th, 2015

Iranian Scientists Use Artemisia Annua Plant to Produce Breast Cancer Drugs August 29th, 2015

Announcements

$200K Awarded to Develop In Vitro Lung Test for Toxicity of Inhaled Nanomaterials: In Vitro Lung Test Designed to Protect Human Health and Replace Animal Testing September 1st, 2015

Hot electrons point the way to perfect light absorption: Physicists study how to achieve perfect absorption of light with the help of rough ultrathin films September 1st, 2015

Using DNA origami to build nanodevices of the future September 1st, 2015

Nanotech could rid cattle of ticks, with less collateral damage September 1st, 2015

Appointments/Promotions/New hires/Resignations/Deaths

National Space Society Welcomes Janet Ivey As New NSS Governor: Janet Ivey of Janet's Planet is NOW IN ORBIT as a member of the Board of Governors of the National Space Society August 27th, 2015

National Space Society Welcomes Geoff Notkin As New NSS Governor August 26th, 2015

Nanostart AG: First-half figures 2015 published and new supervisory board elected : Publication of first-half figures 2015 - Shareholders' meeting elected new supervisory board August 22nd, 2015

Markus Lusser is New President of Leica Microsystems August 11th, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic